<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Karavolias, GK</style></author><author><style face="normal" font="default" size="100%">Adamopoulos, S</style></author><author><style face="normal" font="default" size="100%">Manginas, A.</style></author><author><style face="normal" font="default" size="100%">Iliodromitis, E.K.</style></author><author><style face="normal" font="default" size="100%">Chilidou, D</style></author><author><style face="normal" font="default" size="100%">Cokkinos, D.V.</style></author><author><style face="normal" font="default" size="100%">Kremastinos, D.T.</style></author><author><style face="normal" font="default" size="100%">Alivizatos, PA</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">P3264 Milrinone versus dobutamine as continuous outpatient parenteral inotropic therapy in pre-transplant chronic heart failure patients with reversible pulmonary hypertension: long-term effects</style></title><secondary-title><style face="normal" font="default" size="100%">European Heart Journal</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2003</style></year></dates><number><style face="normal" font="default" size="100%">24</style></number><volume><style face="normal" font="default" size="100%">5</style></volume><pages><style face="normal" font="default" size="100%">617</style></pages><language><style face="normal" font="default" size="100%">eng</style></language></record></records></xml>